Parkland Health and Hospital System, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Antimicrob Agents Chemother. 2012 Nov;56(11):6001-2. doi: 10.1128/AAC.00700-12. Epub 2012 Aug 13.
Voriconazole is the preferred antifungal agent for Aspergillus infections. Therapeutic drug monitoring is recommended to achieve target concentrations and prevent toxicity. However, variable pharmacokinetics, cytochrome P450 polymorphisms, and extensive drug-drug interactions can contribute to subtherapeutic concentrations. We report a voriconazole "boosting" effect of omeprazole to achieve target concentrations for the treatment of Aspergillus in a patient who had persistently subtherapeutic trough concentrations.
伏立康唑是治疗曲霉菌感染的首选抗真菌药物。建议进行治疗药物监测以达到目标浓度并预防毒性。然而，药代动力学的可变性、细胞色素 P450 多态性和广泛的药物相互作用可能导致治疗浓度不足。我们报告了一例奥美拉唑增强伏立康唑作用的病例，该患者持续存在治疗谷浓度不足，使用奥美拉唑后达到了治疗曲霉菌的目标浓度。
